JPS6358839B2 - - Google Patents
Info
- Publication number
- JPS6358839B2 JPS6358839B2 JP56098113A JP9811381A JPS6358839B2 JP S6358839 B2 JPS6358839 B2 JP S6358839B2 JP 56098113 A JP56098113 A JP 56098113A JP 9811381 A JP9811381 A JP 9811381A JP S6358839 B2 JPS6358839 B2 JP S6358839B2
- Authority
- JP
- Japan
- Prior art keywords
- water
- echinoside
- methanol
- sea cucumber
- solvent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 53
- JEBRMYZXRSTSKU-UHFFFAOYSA-N echinoside a Chemical compound [Na+].OC1C(OC)C(O)C(CO)OC1OC1C(O)C(OC2C(C(O)C(OC3C(OCC(C3O)OS(O)(=O)=O)OC3C(C4C(C=5C(C6(CCC7(O)C(C)(CCCC(C)C)OC(=O)C76C(O)C=5)C)CC4)(C)CC3)(C)C)OC2C)O)OC(CO)C1O JEBRMYZXRSTSKU-UHFFFAOYSA-N 0.000 claims description 21
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 18
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 claims description 13
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 12
- 241000251511 Holothuroidea Species 0.000 claims description 10
- 239000002904 solvent Substances 0.000 claims description 9
- 239000000203 mixture Substances 0.000 claims description 8
- 239000003960 organic solvent Substances 0.000 claims description 8
- 238000004519 manufacturing process Methods 0.000 claims description 7
- 238000000034 method Methods 0.000 claims description 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 16
- 229940121375 antifungal agent Drugs 0.000 description 9
- 239000003429 antifungal agent Substances 0.000 description 9
- 235000019441 ethanol Nutrition 0.000 description 7
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 6
- 238000001953 recrystallisation Methods 0.000 description 6
- 239000003795 chemical substances by application Substances 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 4
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- 241001213444 Bohadschia Species 0.000 description 3
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- SIHHLZPXQLFPMC-UHFFFAOYSA-N chloroform;methanol;hydrate Chemical compound O.OC.ClC(Cl)Cl SIHHLZPXQLFPMC-UHFFFAOYSA-N 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- 239000002609 medium Substances 0.000 description 3
- 239000011259 mixed solution Substances 0.000 description 3
- 238000000746 purification Methods 0.000 description 3
- BWMISRWJRUSYEX-SZKNIZGXSA-N terbinafine hydrochloride Chemical compound Cl.C1=CC=C2C(CN(C\C=C\C#CC(C)(C)C)C)=CC=CC2=C1 BWMISRWJRUSYEX-SZKNIZGXSA-N 0.000 description 3
- 201000004647 tinea pedis Diseases 0.000 description 3
- 238000005406 washing Methods 0.000 description 3
- 241001188173 Actinopyga echinites Species 0.000 description 2
- 229920001817 Agar Polymers 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 241000529895 Stercorarius Species 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 239000008272 agar Substances 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 230000000843 anti-fungal effect Effects 0.000 description 2
- 239000000969 carrier Substances 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 2
- -1 lower alcohols (eg Chemical compound 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 239000008194 pharmaceutical composition Substances 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
- 239000001993 wax Substances 0.000 description 2
- FRPZMMHWLSIFAZ-UHFFFAOYSA-N 10-undecenoic acid Chemical compound OC(=O)CCCCCCCCC=C FRPZMMHWLSIFAZ-UHFFFAOYSA-N 0.000 description 1
- UFBJCMHMOXMLKC-UHFFFAOYSA-N 2,4-dinitrophenol Chemical compound OC1=CC=C([N+]([O-])=O)C=C1[N+]([O-])=O UFBJCMHMOXMLKC-UHFFFAOYSA-N 0.000 description 1
- SBASXUCJHJRPEV-UHFFFAOYSA-N 2-(2-methoxyethoxy)ethanol Chemical compound COCCOCCO SBASXUCJHJRPEV-UHFFFAOYSA-N 0.000 description 1
- XNWFRZJHXBZDAG-UHFFFAOYSA-N 2-METHOXYETHANOL Chemical compound COCCO XNWFRZJHXBZDAG-UHFFFAOYSA-N 0.000 description 1
- 241001213448 Actinopyga Species 0.000 description 1
- 241000222122 Candida albicans Species 0.000 description 1
- 206010007134 Candida infections Diseases 0.000 description 1
- 229930186147 Cephalosporin Natural products 0.000 description 1
- IIUZTXTZRGLYTI-UHFFFAOYSA-N Dihydrogriseofulvin Natural products COC1CC(=O)CC(C)C11C(=O)C(C(OC)=CC(OC)=C2Cl)=C2O1 IIUZTXTZRGLYTI-UHFFFAOYSA-N 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- UXWOXTQWVMFRSE-UHFFFAOYSA-N Griseoviridin Natural products O=C1OC(C)CC=C(C(NCC=CC=CC(O)CC(O)C2)=O)SCC1NC(=O)C1=COC2=N1 UXWOXTQWVMFRSE-UHFFFAOYSA-N 0.000 description 1
- 229920000715 Mucilage Polymers 0.000 description 1
- DDUHZTYCFQRHIY-UHFFFAOYSA-N Negwer: 6874 Natural products COC1=CC(=O)CC(C)C11C(=O)C(C(OC)=CC(OC)=C2Cl)=C2O1 DDUHZTYCFQRHIY-UHFFFAOYSA-N 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 239000004098 Tetracycline Substances 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- RJGDLRCDCYRQOQ-UHFFFAOYSA-N anthrone Chemical compound C1=CC=C2C(=O)C3=CC=CC=C3CC2=C1 RJGDLRCDCYRQOQ-UHFFFAOYSA-N 0.000 description 1
- 230000001032 anti-candidal effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000012911 assay medium Substances 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- KTUQUZJOVNIKNZ-UHFFFAOYSA-N butan-1-ol;hydrate Chemical compound O.CCCCO KTUQUZJOVNIKNZ-UHFFFAOYSA-N 0.000 description 1
- 201000003984 candidiasis Diseases 0.000 description 1
- KHAVLLBUVKBTBG-UHFFFAOYSA-N caproleic acid Natural products OC(=O)CCCCCCCC=C KHAVLLBUVKBTBG-UHFFFAOYSA-N 0.000 description 1
- 229940124587 cephalosporin Drugs 0.000 description 1
- 150000001780 cephalosporins Chemical class 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 238000003113 dilution method Methods 0.000 description 1
- NEWIILAQDSMNML-UHFFFAOYSA-L dipotassium;3,4,5,6-tetraoxocyclohexene-1,2-diolate Chemical compound [K+].[K+].[O-]C1=C([O-])C(=O)C(=O)C(=O)C1=O NEWIILAQDSMNML-UHFFFAOYSA-L 0.000 description 1
- 239000002270 dispersing agent Substances 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 238000000921 elemental analysis Methods 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- PGBHMTALBVVCIT-VCIWKGPPSA-N framycetin Chemical compound N[C@@H]1[C@@H](O)[C@H](O)[C@H](CN)O[C@@H]1O[C@H]1[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](N)C[C@@H](N)[C@@H]2O)O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CN)O2)N)O[C@@H]1CO PGBHMTALBVVCIT-VCIWKGPPSA-N 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- DDUHZTYCFQRHIY-RBHXEPJQSA-N griseofulvin Chemical compound COC1=CC(=O)C[C@@H](C)[C@@]11C(=O)C(C(OC)=CC(OC)=C2Cl)=C2O1 DDUHZTYCFQRHIY-RBHXEPJQSA-N 0.000 description 1
- 229960002867 griseofulvin Drugs 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 239000003410 keratolytic agent Substances 0.000 description 1
- 231100000053 low toxicity Toxicity 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 238000005192 partition Methods 0.000 description 1
- 239000006072 paste Substances 0.000 description 1
- 230000000149 penetrating effect Effects 0.000 description 1
- 150000002960 penicillins Chemical class 0.000 description 1
- 229940057838 polyethylene glycol 4000 Drugs 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 229940084106 spermaceti Drugs 0.000 description 1
- 239000012177 spermaceti Substances 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 238000003892 spreading Methods 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 229960005322 streptomycin Drugs 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000000375 suspending agent Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 235000019364 tetracycline Nutrition 0.000 description 1
- 150000003522 tetracyclines Chemical class 0.000 description 1
- 229940040944 tetracyclines Drugs 0.000 description 1
- 229960002703 undecylenic acid Drugs 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
Landscapes
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Description
本発明は抗真菌剤などとして有用なエキノサイ
ドAの新規製造法に関する。
エキノサイド(Echinoside)Aは特願昭54−
160181号に記載されているとおり、ナマコ類
(Holothuroidea)のアクチノピーガ
(Actinopyga)属に属するアクチノピーガ・エキ
ニーテス(Actinopyga echinites JAEGER)か
ら単離された抗真菌活性を有するオリゴ配糖体で
あり、次の構造式で表わされる。
エキノサイドAの性状は次のとおりである。
(1) 分子式(分子量)
C54H87O26SNa(1206)
(2) 元素分析 C54H87O26SNa・2H2Oとして
計算値 C52.16;H7.38;S2.58
実験値 C52.41;H7.37;S2.42
(3) 融点 228〜230℃(80%EtOH)
(4) 〔α〕12 D−6.0゜(pyridine、C=1.36)
(5) 210nmより長波長には紫外吸収を示さない。
(6) IR(KBr、cm-1) 3380(vs*)、2940(s)、
2850(sh)、1760(sh)、1745(s)、1635(s)、
1460(s)、1385(s)、1260(s)、1070(s)、
945(w)、895(w)、820(w)、780(w)
*vs 非常に強い
s 強い
m 中程度
w 弱い
(7) CHCl3、アセトンに溶けない。
メタノール、エタノール、水に溶けにくい。
含水メタノール、含水エタノールに溶ける。
DMSO、ピリジンによく溶ける。
(8) 呈色反応(TLC)
発色試薬 Ehrlich……negative
B.C.G.……negative
Anthrone……青
2,4−DNP……橙
1%Ce(SO4)2・10%H2SO4……赤紫色
potassium rhodizonate test……陽性(オレ
ンジ)
(9) 臭いはなく中性物質である。
(10) 無色針状晶である。
(11) CD(MeOH、c=0.196)、〔θ〕2480、〔θ〕223
−4000(neg、max)、〔θ〕2160、〔θ〕212+4500
(end absorption)
(12) Rf 0.08
TLC Kieselgel 60F254
展開溶媒 CHCl3−MeOH−H2O=65:
35:10(下層)
本発明者らはさらに研究を重ねた結果、アクチ
ノピーガ属とは異なるボハドシア(Bohadschia)
属のクロテナマコ(Bohadschia graeffei SEM
PER)を用いてエキノサイドAを極めて高収率
で抽出することに成功し、これに基づいて本発明
を完成した。
すなわち本発明は、クロテナマコの体壁を溶媒
抽出することを特徴とするエキノサイドAの製造
法である。
溶媒抽出はエキノサイドAを溶解し得る水およ
び/または親水性有機溶媒、たとえば低級アルコ
ール(例、メタノール、エタノール、プロパノー
ル)、アセトンなどを用いて抽出することにより
行われる。溶媒の使用量はクロテナマコの体壁1
Kgに対して、たとえばメタノールの場合、通常約
1〜5程度である。有機溶媒による抽出は含水
状態で行うのが望ましいが、通常ナマコ体壁中に
含まれる水分でこの役割を果すことができる。抽
出は一般に熱抽出が効率良く、通常溶媒の沸点ま
たはそれ以下の温度で行われ、とりわけ還流下に
行うのが好都合である。
抽出液は減圧下に濃縮し、その残渣を水および
水と混らずエキノサイドAを溶解し得る有機溶媒
(例、ブタノール)の混液で分配する。混液中の
水と非水溶性有機溶媒の比率は、通常約1:1で
差し支えないが、必要により適宜調整し得る。
上記分配によつて得られる有機溶媒層を減圧下
に濃縮した後、その残渣を精製することによつて
エキノサイドAが高収率で得られる。精製法とし
ては、たとえば再結晶、カラムクロマトグラフイ
ーなどがあげられる。再結晶による精製は、まず
上記濃縮残渣をエキノサイドAを溶解し難い適当
な溶媒またはその混液で洗浄することによつて可
溶性部分を除き、ついで通常の再結晶操作を行う
のが望ましい。洗浄液としては、たとえばクロロ
ホルム−メタノール−水の混液が好都合に用いら
れる。混液は通常容量比で水1に対してクロロホ
ルム3〜5、メタノール10〜20程度の割合で調製
される。洗浄は室温もしくは冷却下で撹拌しなが
ら実施するのが好ましい。洗浄後は通常過によ
つて不溶部(エキノサイドA)を採取し、再結晶
操作に付す。再結晶溶媒としては、たとえばクロ
ロホルム−メタノール−水の混液や含水メタノー
ル、含水エタノール、含水アセトニトリルなどが
あげられる。上記混液を用いる場合、その配合割
合(容量比)は、通常水1に対してクロロホルム
1〜3、メタノール4〜8程度が望ましい。再結
晶操作は常法に従つて実施することができる。
本発明方法によれば、上記のような溶媒操作の
みでも高収率でエキノサイドAを結晶状で製造す
ることができ、工業的にも極めて有利である。本
方法ににおける好ましい実施態様としては、たと
えばクロテナマコの体壁をメタノールで熱抽出
し、抽出液の濃縮残渣を水−ブタノールで分配
後、ブタノール層を濃縮し、その残渣をクロロホ
ルム−メタノール−水の混液で精製してエキノサ
イドAを結晶化するエキノサイドAの製造法があ
げられる。
本方法によつて製造されるエキノサイドAは優
れた抗真菌作用を有し、その抗菌スペクトルも広
いので、抗真菌剤、たとえば抗カビ剤、抗白癬菌
剤、抗カンジダ菌剤などとして、白癬症(例、水
虫など)やカンジダ症などの治療・予防に有用で
ある。
エキノサイドAは毒性が低いので、上記用途に
経口的に用いることもできるが、通常は外用剤と
して非経口的に用いるのが望ましい。かかる外用
の抗真菌剤として用いる場合、エキノサイドAを
微粉末状でそのまま適用するかまたはエキノサイ
ドAを含有する抽出エキスの状態で適用してもよ
いが、通常は適当な担体とともに医薬組成物の形
で使用するのが望ましい。
抗真菌剤としての医薬組成物は、たとえばエキ
ノサイドAを適当な液体担体(たとえば溶剤)に
溶解するか、あるいはこれに分散させ、または適
当な固体担体(たとえば希釈剤、増量剤)と混合
するか、あるいはこれに吸着させ、必要な場合に
はさらにこれらに、適当な添加剤、たとえば乳化
剤、分散剤、懸濁剤、展着剤、浸透剤、湿潤剤、
粘漿剤、安定剤などを添加して、たとえば溶液
剤、顆粒剤、乳剤、懸濁剤、軟膏剤、散剤、噴霧
剤、パスター剤、パツプ剤などを剤型とすること
ができる。
液体担体としては、具体的には例えば水、アル
コール類(たとえばメチルアルコール、エチルア
ルコール、グリコール、グリセリンなど)、グリ
コールエーテル類(たとえばエチレングリコール
モノメチルエーテル、ジエチレングリコールモノ
メチルエーテルなど)等に用いられる。固体担体
としては具体的には、例えばワツクス類(たとえ
ばポリエチレングリコール4000、鯨蝋、木蝋な
ど)等が挙げられる。
抗真菌剤中における有効成分量は、限定される
べきものではないが、たとえば水虫治療の目的で
用いる場合、通常は製剤全体に対してエキノサイ
ドA約0.01〜70重量%、より好ましくは約0.1〜
5重量%である。又、本発明における抗真菌剤は
公知の他の抗真菌剤と同様、たとえばサリチル酸
などの角質溶解剤、たとえばウンデシレン酸、グ
リセオフルビン、フエザチオン等の他の抗菌剤、
たとえばペニシリン類、セフアロスポリン類、ス
トレプトマイシン、フラジオマイシン、テトラサ
イクリン等の他の抗生物質をさらに含んでいても
よい。
上記の抗真菌剤は常法に従つて1日1〜数回患
部に塗布、噴霧などの手段で適用される。
以下に、試験例および実施例によつて本発明を
さらに詳細に説明するが、本発明の範囲がこれら
に限定されるものではない。
試験例
エキノサイドAの抗菌力試験
寒天培地による倍数希釈法を用いエキノサイド
Aの下記試験菌に対する最少生育阻止濃度を求め
た。検定培地は1%グルコース・ブイヨン寒天培
地(PH6.0)で、試験化合物をメタノールに溶解
後、殺菌水で希釈して用いた。培地中の濃度は1/
10になる様調整した。各試験菌は菌液塗抹接種法
を用い、培養は28℃、3日間行なつた。
試験結果を表1に示す。
The present invention relates to a new method for producing Echinoside A, which is useful as an antifungal agent. Echinoside A is a patent application filed in 1982.
As described in No. 160181, it is an oligoglycoside with antifungal activity isolated from Actinopyga echinites JAEGER, which belongs to the genus Actinopyga of the sea cucumber (Holothuroidea), and has the following structure. It is expressed by the formula. The properties of Echinocide A are as follows. (1) Molecular formula (molecular weight) C 54 H 87 O 26 SNa (1206) (2) Elemental analysis C 54 H 87 O 26 SNa・2H 2 O Calculated value C52.16; H7.38; S2.58 Experimental value C52 .41; H7.37; S2.42 (3) Melting point 228-230°C (80% EtOH) (4) [α] 12 D −6.0° (pyridine, C=1.36) (5) For wavelengths longer than 210 nm Does not exhibit ultraviolet absorption. (6) IR (KBr, cm -1 ) 3380 (vs * ), 2940 (s),
2850 (sh), 1760 (sh), 1745 (s), 1635 (s),
1460(s), 1385(s), 1260(s), 1070(s),
945 (w), 895 (w), 820 (w), 780 (w) *vs Very strong s Strong m Moderate w Weak (7) CHCl 3 , not soluble in acetone. Poorly soluble in methanol, ethanol, and water. Soluble in aqueous methanol and aqueous ethanol. Soluble in DMSO and pyridine. (8) Color reaction (TLC) Color reagent Ehrlich...negative BCG...negative Anthrone...blue 2,4-DNP...orange 1%Ce (SO 4 ) 2・10%H 2 SO 4 ...reddish-purple potassium rhodizonate test...Positive (orange) (9) It has no odor and is a neutral substance. (10) Colorless needle crystals. (11) CD (MeOH, c=0.196), [θ] 248 0, [θ] 223
-4000 (neg, max), [θ] 216 0, [θ] 212 +4500
(end absorption) (12) Rf 0.08 TLC Kieselgel 60F 254 developing solvent CHCl 3 −MeOH−H 2 O=65:
35:10 (lower layer) As a result of further research, the present inventors found that Bohadschia, which is different from the genus Actinopiga,
Genus Bohadschia graeffei SEM
We succeeded in extracting echinoside A at an extremely high yield using PER), and based on this, we completed the present invention. That is, the present invention is a method for producing echinocide A, which is characterized by extracting the body wall of the sea cucumber with a solvent. Solvent extraction is performed using water and/or a hydrophilic organic solvent that can dissolve Echinoside A, such as lower alcohols (eg, methanol, ethanol, propanol), acetone, and the like. The amount of solvent used is 1 part of the body wall of the sea cucumber.
For example, in the case of methanol, it is usually about 1 to 5 kg. It is preferable to perform extraction with an organic solvent in a water-containing state, but the water normally contained in the sea cucumber body wall can fulfill this role. Extraction is generally carried out efficiently by thermal extraction, usually at a temperature at or below the boiling point of the solvent, particularly conveniently carried out under reflux. The extract is concentrated under reduced pressure and the residue is partitioned with a mixture of water and an organic solvent (eg, butanol) that is immiscible with water and capable of dissolving Echinoside A. The ratio of water and water-insoluble organic solvent in the mixed solution is usually about 1:1, but can be adjusted as necessary. Echinoside A can be obtained in high yield by concentrating the organic solvent layer obtained by the above distribution under reduced pressure and then purifying the residue. Examples of purification methods include recrystallization and column chromatography. For purification by recrystallization, it is preferable to first remove the soluble portion by washing the concentrated residue with a suitable solvent or a mixture thereof in which Echinoside A is difficult to dissolve, and then perform a normal recrystallization operation. As the cleaning liquid, for example, a mixture of chloroform-methanol-water is conveniently used. The mixed solution is usually prepared in a volume ratio of 1 part water to 3 to 5 parts chloroform and 10 to 20 parts methanol. The washing is preferably carried out at room temperature or under cooling with stirring. After washing, the insoluble part (echinoside A) is collected by ordinary filtration and subjected to recrystallization. Examples of the recrystallization solvent include a mixture of chloroform-methanol-water, aqueous methanol, aqueous ethanol, and aqueous acetonitrile. When using the above-mentioned liquid mixture, the mixing ratio (volume ratio) is usually about 1 to 3 chloroform and 4 to 8 methanol to 1 part water. The recrystallization operation can be carried out according to a conventional method. According to the method of the present invention, echinoside A can be produced in crystalline form in a high yield simply by the above-mentioned solvent manipulation, and is extremely advantageous from an industrial standpoint. In a preferred embodiment of this method, for example, the body wall of a sea cucumber is thermally extracted with methanol, the concentrated residue of the extract is distributed between water and butanol, the butanol layer is concentrated, and the residue is mixed with chloroform, methanol, and water. There is a method for producing echinoside A in which echinoside A is crystallized by purification using a mixed solution. Echinoside A produced by this method has an excellent antifungal effect and has a broad antibacterial spectrum, so it can be used as an antifungal agent, such as an antifungal agent, an antitinea fungus agent, and an anticandida agent. It is useful for treating and preventing conditions such as athlete's foot (for example, athlete's foot) and candidiasis. Since Echinoside A has low toxicity, it can be used orally for the above purposes, but it is usually preferable to use it parenterally as an external preparation. When used as such an antifungal agent for external use, Echinoside A may be applied directly in the form of a fine powder or in the form of an extract containing Echinoside A, but it is usually applied in the form of a pharmaceutical composition with an appropriate carrier. It is preferable to use it in Pharmaceutical compositions as antifungal agents can be prepared, for example, by dissolving or dispersing Echinoside A in a suitable liquid carrier (e.g. a solvent) or by mixing it with a suitable solid carrier (e.g. diluent, filler). , or adsorbed thereto, and if necessary, further admixed with suitable additives such as emulsifiers, dispersants, suspending agents, spreading agents, penetrating agents, wetting agents, etc.
By adding mucilage agents, stabilizers, etc., the formulation can be made into solutions, granules, emulsions, suspensions, ointments, powders, sprays, pastes, poultices, etc. Specific examples of liquid carriers used include water, alcohols (eg, methyl alcohol, ethyl alcohol, glycol, glycerin, etc.), glycol ethers (eg, ethylene glycol monomethyl ether, diethylene glycol monomethyl ether, etc.), and the like. Specific examples of solid carriers include waxes (eg, polyethylene glycol 4000, spermaceti, wax, etc.). The amount of active ingredient in the antifungal agent is not limited, but when used for the purpose of treating athlete's foot, it is usually about 0.01 to 70% by weight of Echinoside A, more preferably about 0.1 to 70% by weight, based on the entire preparation.
It is 5% by weight. In addition, the antifungal agent in the present invention is similar to other known antifungal agents, such as keratolytic agents such as salicylic acid, other antibacterial agents such as undecylenic acid, griseofulvin, fuezathion, etc.
Other antibiotics such as penicillins, cephalosporins, streptomycin, fradiomycin, and tetracyclines may also be included. The above-mentioned antifungal agents are applied to the affected area once to several times a day in accordance with conventional methods, such as by coating or spraying. The present invention will be explained in more detail below using test examples and examples, but the scope of the present invention is not limited thereto. Test Example Antibacterial activity test of Echinocide A The minimum growth-inhibiting concentration of Echinocide A against the following test bacteria was determined using the multiple dilution method using an agar medium. The assay medium was a 1% glucose bouillon agar medium (PH6.0), and the test compound was dissolved in methanol and then diluted with sterilized water. The concentration in the medium is 1/
I adjusted it to be 10. Each test bacterium was cultured at 28°C for 3 days using the bacterial liquid smear inoculation method. The test results are shown in Table 1.
【表】【table】
【表】
実施例
エキノサイドAの製造
クロテナマコBohadschia graeffei(SEM
PER)の体壁120匹(14Kg)を細かく切断した
後、メタノール(20)で熱抽出(3回)する。
メタノールを減圧濃縮し得られる残渣(70g)
を、水−ブタノール(約10−約10)で分配す
る。ブタノール層を減圧濃縮し得られる残渣
(230g)にクロロホルム(400ml)、メタノール
(1500ml)、水(100ml)を加え、室温(15℃)で
24時間撹拌した後、過し不溶部(130g)を得
る。不溶部6gをクロロホルム(80ml)−メタノ
ール(240ml)−水(40ml)から再結晶しエキノサ
イドA5g(45%from n−BuOH ext.)を得る。
上記クロテナマコより得られたエキノサイドA
は、Actinopyga echinites(Jaeger)より得ら
れている標品のエキノサイドAと混融、〔α〕D、
13CNMRにより同定した。[Table] Example Production of Echinocide A Black sea cucumber Bohadschia graeffei (SEM
After cutting the body walls of 120 (14 kg) PER) into small pieces, they were heat-extracted (3 times) with methanol (20).
Residue obtained by concentrating methanol under reduced pressure (70g)
Partition water-butanol (ca. 10-ca. 10). The butanol layer was concentrated under reduced pressure, and chloroform (400 ml), methanol (1500 ml), and water (100 ml) were added to the resulting residue (230 g), and the mixture was heated at room temperature (15°C).
After stirring for 24 hours, filter the insoluble portion (130 g). 6 g of the insoluble portion was recrystallized from chloroform (80 ml) - methanol (240 ml) - water (40 ml) to obtain 5 g of echinoside A (45% from n-BuOH ext.). Echinocide A obtained from the above sea cucumber
is mixed with standard echinocide A obtained from Actinopyga echinites (Jaeger), [α] D ,
13 Identified by CNMR.
Claims (1)
徴とするエキノサイドAの製造法。 2 特許請求の範囲第1項記載の方法において、
クロテナマコの体壁を親水性有機溶媒で抽出し、
抽出物を水−非水溶性有機溶媒で分配後、有機溶
媒層からエキノサイドAを結晶化させるエキノサ
イドAの製造法。 3 特許請求の範囲第1項記載の方法において、
クロテナマコの体壁のメタノールで熱抽出し、抽
出液の濃縮残渣を水−ブタノールで分配後、ブタ
ノール層を濃縮し、その残渣をクロロホルム−メ
タノール−水の混液で精製してエキノサイドAを
結晶化させるエキノサイドAの製造法。[Claims] 1. A method for producing echinocide A, which comprises extracting the body wall of a sea cucumber with a solvent. 2. In the method described in claim 1,
Extract the body wall of the sea cucumber with a hydrophilic organic solvent,
A method for producing echinoside A, which comprises distributing the extract between water and a water-insoluble organic solvent, and then crystallizing echinoside A from the organic solvent layer. 3. In the method described in claim 1,
The body wall of the sea cucumber is thermally extracted with methanol, the concentrated residue of the extract is distributed between water and butanol, the butanol layer is concentrated, and the residue is purified with a mixture of chloroform, methanol, and water to crystallize echinoside A. Method for producing echinocide A.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP56098113A JPS57212200A (en) | 1981-06-23 | 1981-06-23 | Preparation of echinoside a |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP56098113A JPS57212200A (en) | 1981-06-23 | 1981-06-23 | Preparation of echinoside a |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS57212200A JPS57212200A (en) | 1982-12-27 |
JPS6358839B2 true JPS6358839B2 (en) | 1988-11-17 |
Family
ID=14211260
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP56098113A Granted JPS57212200A (en) | 1981-06-23 | 1981-06-23 | Preparation of echinoside a |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS57212200A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2004517172A (en) * | 2001-03-30 | 2004-06-10 | カウンシル・オブ・サイエンティフィック・アンド・インダストリアル・リサーチ | Natural fluorescent dyes obtained from marine invertebrates, compositions containing said dyes, and uses thereof |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4629623A (en) * | 1984-06-11 | 1986-12-16 | Biomatrix, Inc. | Hyaluronate-poly (ethylene oxide) compositions and cosmetic formulations thereof |
AU684828B2 (en) * | 1993-08-19 | 1998-01-08 | Merck Sharp & Dohme Corp. | Thermodynamically stable crystal form of 4"-deoxy-4"-(epi)-methylamino avermectin B1a/B1b benzoic acid salt and processes for its preparation |
US6055936A (en) * | 1997-01-21 | 2000-05-02 | Collin; Peter Donald | Sea cucumber carotenoid lipid fractions and process |
AU2003300712A1 (en) * | 2003-12-31 | 2005-07-21 | Council Of Scientific And Industrial Research | Isolation of bivittoside d from sea cucumber and activity thereof |
CN106636286B (en) * | 2016-12-28 | 2021-07-27 | 中国海洋大学 | Desugarized sea cucumber secondary saponin and preparation method thereof |
-
1981
- 1981-06-23 JP JP56098113A patent/JPS57212200A/en active Granted
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2004517172A (en) * | 2001-03-30 | 2004-06-10 | カウンシル・オブ・サイエンティフィック・アンド・インダストリアル・リサーチ | Natural fluorescent dyes obtained from marine invertebrates, compositions containing said dyes, and uses thereof |
Also Published As
Publication number | Publication date |
---|---|
JPS57212200A (en) | 1982-12-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPS6123192B2 (en) | ||
Petroski et al. | Isolation, semi-synthesis, and NMR spectral studies of loline alkaloids | |
DD271705A5 (en) | METHOD FOR PRODUCING AZITHROMYCINE DIHYDRATE | |
US3945993A (en) | Derivatives of polyene macrolide antibiotics | |
JPS6358839B2 (en) | ||
US4035568A (en) | Derivatives of polyene macrolide antibiotics | |
DE2651773C3 (en) | 14-Acyloxy-daunorubicins, processes for their preparation and pharmaceutical compositions containing these compounds | |
CA1124235A (en) | Method for preparing new 1,8-dihydroxy-10-acyl-9- anthrones for the treatment of psoriasis | |
DE1643835B2 (en) | 21-ALDEHYDE OF THE PREGN SERIES AND ITS DERIVATIVES, THE PROCESS FOR THEIR PRODUCTION AND THE PHARMACEUTICAL PREPARATIONS CONTAINING THESE | |
JPS6245880B2 (en) | ||
DE2221939C3 (en) | 2- (3-Pyridazinyl) -3- (4-methylpiperazino-carbonyloxy) -1-isoindolinone derivatives, processes for their preparation and pharmaceutical compositions containing them | |
JPH0368880B2 (en) | ||
Dale | PREPARATION OF BROMOACETYLGLUCOSE AND CERTAIN OTHER BROMOACETYL SUGARS. | |
US2161114A (en) | Soluble double salts of theophylline and monoamino polyhydric alcohols | |
DE2632115A1 (en) | NEW SEROTONE DERIVATIVES, PROCESS FOR THEIR MANUFACTURING AND MEDICINAL PRODUCTS CONTAINING THEM | |
JP3053205B2 (en) | Chemical derivatives of the antibiotic LL-E19020 alpha and beta | |
DE1770351C2 (en) | 2-0-Acyl-clindamycins, processes for their preparation and antibiotic preparations containing these compounds | |
DE1695849A1 (en) | Process for the preparation of new pyrimidine derivatives | |
IL22583A (en) | Pilocarpine benzoate | |
EP0175264B1 (en) | Process for the preparation of 2-amino-3-cyano-5-dialkoxymethyl pyrazines and intermediates for this process | |
JPS5821601B2 (en) | Shinkidioxan Yudoutai Oyobi Sonoseizouhou Narabini Youto | |
JPS6219598A (en) | 2,3,2'3'-tetra-o-alkyl-alpha,alpha-trehalose derivative | |
DE3317159C2 (en) | ||
EP0181409A1 (en) | 15(r+s)-fluorine-11,15-didesoxyprostaglandin e 1? derivatives | |
DE2230031A1 (en) | Chlorhexidine salts and processes for their preparation |